Sintx Technologies, Inc. (SINT) stock
SINTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3011% above fair value
$1.34−0.20 (-12.66%)
Close on Nov 13, 2026Market cap $8.96MP/E –Yield –
Sintx Technologies r&d expenses
Research and development expenses are spending on new products and technology.
Sintx Technologies's R&D Expenses for the twelve months ending Sep 30, 2026 was $2.45M, down 43.3% year over year. For fiscal 2025 it was $4.59M, down 11.8% from the year before. Over ten years it grew -3.3% a year on average. The highest annual figure on record is $8.71M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.59M | -11.8% |
| FY2024 | Dec 31, 2024 | $5.20M | -40.3% |
| FY2023 | Dec 31, 2023 | $8.71M | +35.1% |
| FY2022 | Dec 31, 2022 | $6.45M | +9.6% |
| FY2021 | Dec 31, 2021 | $5.89M | +22.4% |
| FY2020 | Dec 31, 2020 | $4.81M | +41.7% |
| FY2019 | Dec 31, 2019 | $3.39M | +13.5% |
| FY2018 | Dec 31, 2018 | $2.99M | -14.7% |
| FY2017 | Dec 31, 2017 | $3.51M | -44.7% |
| FY2016 | Dec 31, 2016 | $6.35M | -0.7% |
| FY2015 | Dec 31, 2015 | $6.39M | -5.3% |
| FY2014 | Dec 31, 2014 | $6.74M | +94.8% |
| FY2013 | Dec 31, 2013 | $3.46M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $548.00K | -56.6% |
| Q2 FY2026 | Jun 30, 2026 | $573.00K | -53.7% |
| Q1 FY2026 | Mar 31, 2026 | $364.00K | -67.4% |
| Q4 FY2025 | Dec 31, 2025 | $969.00K | +36.7% |
| Q3 FY2025 | Sep 30, 2025 | $1.26M | +58.8% |
| Q2 FY2025 | Jun 30, 2025 | $1.24M | -26.2% |
| Q1 FY2025 | Mar 31, 2025 | $1.12M | -44.7% |
| Q4 FY2024 | Dec 31, 2024 | $709.00K | -61.1% |
| Q3 FY2024 | Sep 30, 2024 | $796.00K | -68.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.68M | -21.9% |
| Q1 FY2024 | Mar 31, 2024 | $2.02M | -8.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.82M | +1.4% |
| Q3 FY2023 | Sep 30, 2023 | $2.53M | +65.8% |
| Q2 FY2023 | Jun 30, 2023 | $2.15M | +45.5% |
| Q1 FY2023 | Mar 31, 2023 | $2.20M | +33.1% |
| Q4 FY2022 | Dec 31, 2022 | $1.80M | +21.2% |
| Q3 FY2022 | Sep 30, 2022 | $1.52M | -5.0% |
| Q2 FY2022 | Jun 30, 2022 | $1.48M | +22.6% |
| Q1 FY2022 | Mar 31, 2022 | $1.65M | +3.6% |
| Q4 FY2021 | Dec 31, 2021 | $1.48M | +12.9% |
| Q3 FY2021 | Sep 30, 2021 | $1.60M | +11.9% |
| Q2 FY2021 | Jun 30, 2021 | $1.20M | +12.7% |
| Q1 FY2021 | Mar 31, 2021 | $1.60M | +60.5% |
| Q4 FY2020 | Dec 31, 2020 | $1.31M | +57.0% |
| Q3 FY2020 | Sep 30, 2020 | $1.43M | +64.8% |
| Q2 FY2020 | Jun 30, 2020 | $1.07M | +27.8% |
| Q1 FY2020 | Mar 31, 2020 | $994.00K | +38.4% |
| Q4 FY2019 | Dec 31, 2019 | $837.00K | +37.7% |
| Q3 FY2019 | Sep 30, 2019 | $869.00K | +58.3% |
| Q2 FY2019 | Jun 30, 2019 | $836.00K | -12.6% |
| Q1 FY2019 | Mar 31, 2019 | $718.00K | -18.1% |
| Q4 FY2018 | Dec 31, 2018 | $608.00K | -31.1% |
| Q3 FY2018 | Sep 30, 2018 | $549.00K | -46.3% |
| Q2 FY2018 | Jun 30, 2018 | $956.00K | -28.8% |
| Q1 FY2018 | Mar 31, 2018 | $877.00K | -13.7% |
| Q4 FY2017 | Dec 31, 2017 | $882.00K | -44.9% |
| Q3 FY2017 | Sep 30, 2017 | $1.02M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.34M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.02M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.60M | – |
See a number that looks wrong?